- Home
- EVAX vs PRZO Comparison
EVAX vs PRZO Comparison
Compare EVAX & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- PRZO
- Stock Information
- Founded
- EVAX 2008
- PRZO 2014
- Country
- EVAX Denmark
- PRZO Israel
- Employees
- EVAX N/A
- PRZO N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- PRZO
- Sector
- EVAX Health Care
- PRZO
- Exchange
- EVAX Nasdaq
- PRZO Nasdaq
- Market Cap
- EVAX 8.7M
- PRZO 7.8M
- IPO Year
- EVAX 2021
- PRZO 2023
- Fundamental
- Price
- EVAX $0.89
- PRZO $1.93
- Analyst Decision
- EVAX Strong Buy
- PRZO
- Analyst Count
- EVAX 2
- PRZO 0
- Target Price
- EVAX $11.00
- PRZO N/A
- AVG Volume (30 Days)
- EVAX 82.5K
- PRZO 21.5M
- Earning Date
- EVAX 10-31-2024
- PRZO 12-27-2024
- Dividend Yield
- EVAX N/A
- PRZO N/A
- EPS Growth
- EVAX N/A
- PRZO N/A
- EPS
- EVAX N/A
- PRZO N/A
- Revenue
- EVAX $3,295,000.00
- PRZO $558,382.00
- Revenue This Year
- EVAX $4,845.21
- PRZO N/A
- Revenue Next Year
- EVAX $30.30
- PRZO N/A
- P/E Ratio
- EVAX N/A
- PRZO N/A
- Revenue Growth
- EVAX N/A
- PRZO N/A
- 52 Week Low
- EVAX $0.85
- PRZO $0.49
- 52 Week High
- EVAX $13.61
- PRZO $2.77
- Technical
- Relative Strength Index (RSI)
- EVAX 21.83
- PRZO 65.50
- Support Level
- EVAX $0.85
- PRZO $1.69
- Resistance Level
- EVAX $0.96
- PRZO $2.77
- Average True Range (ATR)
- EVAX 0.15
- PRZO 0.32
- MACD
- EVAX -0.00
- PRZO 0.04
- Stochastic Oscillator
- EVAX 5.75
- PRZO 52.03
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the comapany applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.